Prognosis of patients with diabetic macular edema before Japanese approval of anti-vascular endothelial growth factor

Serizawa Satoshi; Ohkoshi Kishiko; Minowa Yuko; Takahashi Osamu

首页> 外文期刊>Japanese Journal of Ophthalmology >Prognosis of patients with diabetic macular edema before Japanese approval of anti-vascular endothelial growth factor

【24h】

Prognosis of patients with diabetic macular edema before Japanese approval of anti-vascular endothelial growth factor

机译：日本批准抗血管内皮生长因子前，糖尿病性黄斑水肿患者的预后

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose To examine the prognosis of patients with diabetic macular edema (DME) before Japanese approval of antivascular endothelial growth factor (VEGF).

机译：目的在日本批准抗血管内皮生长因子（VEGF）之前检查糖尿病性黄斑水肿（DME）患者的预后。

著录项

来源
《Japanese Journal of Ophthalmology》 |2015年第4期|共8页
作者
Serizawa Satoshi; Ohkoshi Kishiko; Minowa Yuko; Takahashi Osamu;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
Diabetic macular edema; Ranibizumab; Vitrectomy; Optic coherence tomography; Diabetic retinopathy;

机译：糖尿病性黄斑水肿;雷珠单抗;玻璃体切除术;光学相干断层扫描;糖尿病性视网膜病变;

相似文献

外文文献
中文文献
专利

1. Prognosis of patients with diabetic macular edema before Japanese approval of anti-vascular endothelial growth factor [J] . Serizawa Satoshi, Ohkoshi Kishiko, Minowa Yuko, Japanese Journal of Ophthalmology . 2015,第4期

机译：日本批准抗血管内皮生长因子前，糖尿病性黄斑水肿患者的预后
2. Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients [J] . Nakhleh E Abu-Yaghi, Alaa M Abed, Dana F Khlaifat, Clinical ophthalmology . 2020,第4期

机译：影响血管内皮生长因子糖尿病患者队列糖尿病性黄昏生长因子治疗的因素
3. Factors Predicting Treatment Response in Anti-Vascular Endothelial Growth Factor Na?ve Diabetic Macular Edema Patients Treated with Intravitreal Bevacizumab [J] . Alastair David Bezzina, Francis Carbonaro Journal of ocular pharmacology and therapeutics: The official journal of the Association for Ocular Pharmacology and Therapeutics . 2019,第10期

机译：预测术治疗抗血管内皮生长因子Naβve糖尿病患者治疗术治疗的因素
4. Detection of Serum Vascular Endothelial Growth Factor (VEGF) and Endothelin, in Type 2 Diabetic Nephropathy Patients and Its Clinical Significance [C] . Yongqiang Zheng, Jianfen Wei, Xiaojun Li, International conference on green communications and networks;GCN 2011 . 2011

机译：2型糖尿病肾病患者血清血管内皮生长因子（VEGF）和内皮素的检测及其临床意义
5. Prediction of visual acuity loss and indications for laser treatment in patients with diabetic macular edema using the Heidelberg Retina Tomograph. [D] . O'Neal, Dennis A. 2007

机译：使用海德堡视网膜断层扫描仪预测糖尿病性黄斑水肿患者的视力下降和激光治疗的适应症。
6. Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema [O] . Davis Bhagat, Breanne Kirby, Harit Bhatt, 2020

机译：与抗血管内皮生长因子疗法相关的患者偏好用于新生血管年龄相关的黄斑变性和糖尿病黄斑水肿
7. >Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients [O] . Nakhleh E Abu-Yaghi, Alaa M Abed, Dana F Khlaifat, 2020

机译：>影响依血管内皮生长因子治疗糖尿病患者队列糖尿病患者水肿的因素

Prognosis of patients with diabetic macular edema before Japanese approval of anti-vascular endothelial growth factor

摘要

著录项

相似文献

相关主题

期刊订阅